American Vietnamese Biotech (HSTC:AMV) EBITDA Margin %: 0.00% (As of . 20)


What is American Vietnamese Biotech EBITDA Margin %?

American Vietnamese Biotech HSTC:AMV EBITDA Margin % is 0.00% as of . 20.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. American Vietnamese Biotech's EBITDA for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, American Vietnamese Biotech's EBITDA margin for the quarter that ended in . 20 was 0.00%.

American Vietnamese Biotech  (HSTC:AMV) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

American Vietnamese Biotech EBITDA Margin % Related Terms

American Vietnamese Biotech EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech EBITDA Margin % Chart

American Vietnamese Biotech Annual Data
Trend
EBITDA Margin %

American Vietnamese Biotech Quarterly Data
EBITDA Margin %

HSTC:AMV vs HSTC, STLT, CTBO: EBITDA Margin % Comparison

For the Biotechnology subindustry, American Vietnamese Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Vietnamese Biotech EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's EBITDA Margin % falls into.


American Vietnamese Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

American Vietnamese Biotech's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

American Vietnamese Biotech's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
American Vietnamese Biotech (HSTC:AMV) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's EBITDA Margin % too high?
American Vietnamese Biotech's current EBITDA Margin % is 0.00%.
How does American Vietnamese Biotech's EBITDA Margin % compare to HSTC and STLT?
American Vietnamese Biotech's EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.